Company Overview and News


Add MDXG
to your dashboard

Headline News

Hero to Short Sellers Rose From Social Work to Steinhoff Win - Bloomberg

7h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (8-0)

BRIEF-Mimedx Announces First Patients Have Been Enrolled In The Phase 3 Clinical Trial Of Amniofix

2018-01-16 reuters
* MIMEDX ANNOUNCES FIRST PATIENTS HAVE BEEN ENROLLED IN THE PHASE 3 CLINICAL TRIAL OF AMNIOFIX® INJECTABLE IN PATIENTS WITH RECALCITRANT PLANTAR FASCIITIS PAIN (7-0)

Biotech Stocks Near Massive Breakout | Investopedia

2018-01-15 investopedia
(Note: The author of this fundamental analysis is a financial writer and portfolio manager. He and his clients own shares of ALKS.) (148-1)

Faceless Men Upend South Africa Stocks on Fears of Steinhoff 2.0 - Bloomberg

2018-01-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (7-0)

MiMedx: Unique Opportunity Provided By Aggressive Shorts

2018-01-02 seekingalpha
MiMedx Group Inc. (MDXG) has been the focus of unrelenting short attacks for years, but it continues to grow and thrive on best-in-class products with amazing margins. Its growth story has been remarkable, with continued growth on the horizon, as its pipeline of candidates looks to considerably diversify its core revenue streams. (7-1)

BRIEF-MiMedx Agrees To Lawsuit Settlement With Former Employee

2017-12-19 reuters
* MIMEDX GROUP INC - COMPANY HAS AGREED TO A CONFIDENTIAL LAWSUIT SETTLEMENT FROM ONE FORMER EMPLOYEE (7-0)

Biotech Forum Daily Digest: Impacts Of Tax Reform

2017-12-15 seekingalpha
Biotech has been a volatile sector in trading this week. Tax loss selling and uncertainty of what will be in the final tax reform package are both probably impacting trading. (103-1)

Biotech Forum Daily Digest: Our Take On MiMedx

2017-12-05 seekingalpha
After a decent previous week, biotech slid on Monday as money rotated into energy and financial names. (106-3)

BRIEF-Mimedx provides update on its reimbursement coverage

2017-11-21 reuters
* Mimedx Group Inc - ‍provided a reimbursement update in light of FDA final and draft guidance documents related to human tissue​ (7-1)

MiMedx CEO Pete Petit suing short sellers after negative reports - Business Insider

2017-11-10 businessinsider
A flamboyant CEO critics calls the "Trump of Georgia" is engaged in a legal war with the nation's short-sellers — traders who bet a stock price will fall — and searching for the analysts who wrote anonymous blog posts about his small pharmaceutical company, MiMedx Group. (7-2)

petite parker the barker – MiMedx Group Inc (NASDAQ:MDXG)

2017-10-31 petiteparkerthebarker
(7-2)

MiMedx Group's (MDXG) CEO Pete Petit on Q3 2017 Results - Earnings Call Transcript

2017-10-28 seekingalpha
Good day ladies and gentlemen, and welcome to the Q3 2017 MiMedx Group Inc's Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions]. (29-1)

Citron Chimes In On MiMedx. Countdown To Formal Investigation. $3 Price Target

2017-10-25 seekingalpha
Citron would not enter into a “noisy” game unless we can add insight into the short thesis and create a better informed marketplace for mentioned stock. (7-0)

CUSIP: 602496101